Sort
130,381 grants matching “hiv”
Biochemistry core
$1,581,084Robert M Stroud · University Of California, San Francisco · U19 · FY2022 · AI
A Cohort-Sequential Panal Study of Drug Use, Ages 19-50
$1,580,624Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2008 · DA
Molecular Analysis of Tuberculosis Immunity
$1,580,467William Robert Jacobs · Albert Einstein College Of Medicine, Inc · P01 · FY2015 · AI
Lifespan/Tufts/Brown Center for AIDS Research (CFAR)
$1,580,262Charles Cj Carpenter · Miriam Hospital · P30 · FY2011 · AI
Clincial and Specimen Core
$1,580,013Susan Little · University Of California, San Diego · P01 · FY2008 · AI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
$1,579,999Aaron Weinberg · Case Western Reserve University · P01 · FY2012 · DE
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
$1,579,826Melissa Morrison · Tennessee State Department Of Health · U62 · FY2015 · PS
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
$1,579,735Michael Marcel Lederman · Case Western Reserve University · U19 · FY2010 · AI
EXPANDED HIV TESTING
$1,579,533Jack Carrel · Louisiana State Office Of Public Health · U62 · FY2009 · PS
ART Modulation of Viral Pathogenesis
$1,579,497Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DE
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
$1,579,167Howard S. Fox · University Of Nebraska Medical Center · U01 · FY2024 · DA
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
$1,579,040Charlotte Ann Gaydos · Johns Hopkins University · U54 · FY2016 · EB
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,578,849Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA
HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation
$1,578,717Christine Marie Durand · Johns Hopkins University · U01 · FY2017 · AI
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,578,677Jeanette Coffin · Midwest Research Institute · N01 · FY2023 · AI
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,578,386Steven A Yukl · University Of California, San Francisco · P01 · FY2022 · AI
Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic
$1,578,326Robert Walter Buckheit · Imquest Biosciences · U19 · FY2010 · AI
Comprehensive NeuroAIDS Center
$1,578,324Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2020 · MH
CENTER FOR AIDS RESEARCH
$1,578,271New York University School Of Medicine · P30 · FY2003 · AI
Makerere Univ.-Johns Hopkins Univ. HIV Clinical Trials Unit-Kampala, Uganda
$1,577,922Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2012 · AI
CNS &Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,577,602Johns Hopkins University · P01 · FY2005 · MH
Protein Structure
$1,577,338Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza
$1,577,327Dennis Carson · University Of California, San Diego · N01 · FY2017 · AI
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,577,015David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2023 · HL
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,576,889Janice Ellen Clements · Johns Hopkins University · P01 · FY2012 · MH